RecruitingNot ApplicableNCT05035693

Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C

"PMCF MOVE®-C" International, Prospective, Multicentre, Non-randomised Post-market Clinical Follow-up Study Clinical and Radiological Outcome After Mono- and Bisegmental Cervical Intervertebral Disc Prosthetics

Sponsor

NGMedical GmbH

Enrollment

170 participants

Start Date

Mar 11, 2021

Study Type

INTERVENTIONAL

Conditions

Discopathy Herniated Cervical Disc Stenoses, Spinal radiculopathy

Summary

Study design: International, prospective, multicentre, non-randomised, observational study according to § 23b MPG. Objectives: Observational study to confirm the safety and performance of the cervical disc prosthesis MOVE®-C.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called MOVE®-C for people with discopathy, herniated cervical disc, and other related conditions. The study is currently recruiting participants at 7 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.